TFG
REGN icon

Team Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Team Financial Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3
Closed -$2.32K – 207
2026
Q1 		$2.32K Hold
3
– – ﹤0.01% 251
2025
Q4 		$2.32K Hold
3
– – ﹤0.01% 241
2025
Q3 		$1.69K Hold
3
– – ﹤0.01% 241
2025
Q2 		$1.57K Buy
+3
New +$1.67K ﹤0.01% 236

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Team Financial Group's REGN Position: Q2 2026 in Review

Team Financial Group sold out of Regeneron Pharmaceuticals (REGN) in Q2 2026, closing a stake of 3 shares — an estimated $2.32K sold.

Team Financial Group first reported a position in REGN in Q2 2025 and held it in 4 quarters. The position peaked at $2.32K in Q1 2026. 334 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Team Financial Group reported no remaining Regeneron Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Team Financial Group sold 3 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.32K.
  • Team Financial Group first reported a position in Regeneron Pharmaceuticals in Q2 2025 and held it in 4 quarters.
  • Team Financial Group's Regeneron Pharmaceuticals position peaked at $2.32K in Q1 2026.
  • 334 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Team Financial Group's 13F filing for Q2 2026, filed 13 Jul 2026.